App-Quantinova.ai

Real-world data on the use of certolizumab pegol for the treatment of axial spondyloarthritis in clinical practice in Europe: 24-week interim results from a prospective non-interventional cohort study

Nicola Goodson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

Certolizumab pegol

The prevalence and effect of periodontitis on rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis disease activity: a cross-sectional observational study

Michael R C Gough - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Real-world experience of secukinumab for psoriatic arthritis and axial spondyloarthritis

Jamie Robertson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

secukinumab

NKX2-5 is associated to endothelial-to-mesenchymal transition in scleroderma-PAH

Jamil Santos Cade - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

Casein

Multidisciplinary team management of scleroderma: real life experience of a regional specialised service

Luke Flain - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

Bosentan

Patient survey evaluating available pharmacological therapies used to treat severe Raynaud’s phenomenon

Amaani Hussain - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Raynaud syndrome

Epoprostenol

Limitations in study design hamper interpretation of studies evaluating the prognostic value of nailfold capillaroscopy in systemic sclerosis: a systematic literature review

Dolcie Paxton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Relationship between DAS28 categories and rheumatoid arthritis impact of disease (RAID) patient reported outcome in rheumatoid arthritis: significant advantage of targeting DAS remission

Catherine Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Rheumatoid pulmonary nodules as a risk for seropositive rheumatoid arthritis: a reappraisal of the risk of Caplan’s syndrome for rheumatoid arthritis development using historic Cornish data

Emily K Sinha-Royle - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Durability, maintenance and effects of dose reduction following prolonged treatment with baricitinib

Josef S Smolen - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Baricitinib

The effect of a low versus high first prescribed dose of methotrexate on EULAR response at six months using data from the RAMS study

Rebecca Davies - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Biologic dose optimisation in clinical practice

Andrew Blyth - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Certolizumab pegol

Profiling rheumatoid arthritis biosimilar switchers: datafrom the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Diederik De Cock - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Infliximab

Work matters: a UK-wide survey of adults with rheumatoid arthritis and juvenile idiopathic arthritis on the impact of their disease on work

Ailsa Bosworth - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

No evidence that pulmonary fibrosis is a complication of long term methotrexate use: 10 year follow up data of patients treated with methotrexate for inflammatory arthritis

Julie K Dawson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Methotrexate

Rheumatoid arthritis neutrophil extra-cellular traps contain citrullinated histone-H3

Max A Lyon - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Synovial fluid metabolite profiles differ between osteoarthritis and rheumatoid arthritis

James R Anderson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

N/A

Signatures of microbial and autoantibody epitopes in idiopathic inflammatory myopathies

Spyridon Megremis - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic inflammatory myopathies

N/A

IL-6 trans-signaling causes accelerated atherosclerosis in disease-prone animals

Ruth Davies - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Hyper-IL-6

Globalisation of Paediatric Musculoskeletal Matters (PMM)

Nicola Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Methadone hydrochloride

Filters

45280 Abstracts